Covered recipient · General Payments record
GAIL F SCHWARTZ
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$103,111.47
- Reported across 242 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $325.61 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $160.01 | 9 |
| Alcon Laboratories Inc | $75.98 | 3 |
| Bausch & Lomb Americas Inc. | $20.20 | 1 |
| GLAUKOS CORPORATION | $19.52 | 1 |
| NEW WORLD MEDICAL,INC. | $18.23 | 1 |
| Thea Pharma Inc. | $16.05 | 1 |
| Sight Sciences, Inc. | $15.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.82 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044606 | CMS |
| ABBVIE INC. | $8.84 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044608 | CMS |
| ABBVIE INC. | $33.55 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044610 | CMS |
| ABBVIE INC. | $31.72 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044612 | CMS |
| ABBVIE INC. | $6.24 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044614 | CMS |
| ABBVIE INC. | $5.90 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044616 | CMS |
| ABBVIE INC. | $28.91 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044618 | CMS |
| ABBVIE INC. | $7.88 | 11/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044620 | CMS |
| ABBVIE INC. | $8.15 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044622 | CMS |
| Alcon Vision LLC | $23.01 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110565475 | CMS |
| Alcon Vision LLC | $29.65 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110565479 | CMS |
| Alcon Vision LLC | $23.32 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110565477 | CMS |
| Bausch & Lomb Americas Inc. | $20.20 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140346536 | CMS |
| Glaukos Corporation | $19.52 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151985400 | CMS |
| NEW WORLD MEDICAL,INC. | $18.23 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137396817 | CMS |
| Sight Sciences, Inc. | $15.62 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151926024 | CMS |
| Thea Pharma Inc. | $16.05 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074544611 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.